Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
Navya Sree Kola Srinivas, Ruchi Verma, Girish Pai Kulyadi, et al.
International Journal of Nanomedicine (2016) Vol. Volume 12, pp. 15-28
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Solubility determination and three dimensional Hansen solubility parameters of gefitinib in different organic solvents: Experimental and computational approaches
Abdullah Alanazi, Sultan Alshehri, Mohammad A. Altamimi, et al.
Journal of Molecular Liquids (2019) Vol. 299, pp. 112211-112211
Closed Access | Times Cited: 104
Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles
Dhananjay Panigrahi, Pratap Kumar Sahu, Suryakanta Swain, et al.
SN Applied Sciences (2021) Vol. 3, Iss. 6
Open Access | Times Cited: 58
<p>Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats</p>
Karthik Gourishetti, Raghuvir Keni, Pawan G. Nayak, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 9265-9282
Open Access | Times Cited: 63
Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer
Govind Soni, Ketaki Kale, Saritha Shetty, et al.
Heliyon (2020) Vol. 6, Iss. 4, pp. e03846-e03846
Open Access | Times Cited: 58
Design, preparation and in vitro characterizations of fluconazole loaded nanostructured lipid carriers
Amanda Velinna Fernandes, Chinna Raja Pydi, Ruchi Verma, et al.
Brazilian Journal of Pharmaceutical Sciences (2020) Vol. 56
Open Access | Times Cited: 53
Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Ahmad Abdul-Wahhab Shahba, et al.
Molecules (2023) Vol. 28, Iss. 1, pp. 448-448
Open Access | Times Cited: 20
A Tutorial for Developing a Topical Cream Formulation Based on the Quality by Design Approach
Ana Simões, Francisco Veiga, Carla Vitorino, et al.
Journal of Pharmaceutical Sciences (2018) Vol. 107, Iss. 10, pp. 2653-2662
Closed Access | Times Cited: 51
Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy
Nazafarin Satari, Somayeh Taymouri, Jaleh Varshosaz, et al.
Drug Development and Industrial Pharmacy (2020) Vol. 46, Iss. 8, pp. 1265-1277
Closed Access | Times Cited: 45
Quantum Dots Encapsulated with Curcumin Inhibit The Growth of Colon Cancer, Breast Cancer and Bacterial Cells
Firdos Alam Khan, Narimane Lammari, Adeeb Shezad Muhammad Siar, et al.
Nanomedicine (2020) Vol. 15, Iss. 10, pp. 969-980
Closed Access | Times Cited: 41
Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems
Navya Ajitkumar Bhaskaran, Lalit Kumar
Journal of Controlled Release (2021) Vol. 336, pp. 16-39
Closed Access | Times Cited: 35
A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review
Daniela M. Zagalo, Branca M. A. Silva, Cláudia Silva, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 70, pp. 103207-103207
Closed Access | Times Cited: 24
Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model
Zahra Karimi, Somayeh Taymouri, Mohsen Minaiyan, et al.
International Journal of Pharmaceutics (2022) Vol. 624, pp. 122036-122036
Closed Access | Times Cited: 24
A practical framework for implementing Quality by Design to the development of topical drug products: Nanosystem-based dosage forms
Ana Simões, Francisco Veiga, Ana Figueiras, et al.
International Journal of Pharmaceutics (2018) Vol. 548, Iss. 1, pp. 385-399
Closed Access | Times Cited: 45
Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy
Juan Chen, Xiaobing Yang, Liuqing Huang, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 1932-1942
Open Access | Times Cited: 44
Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound
Jing Wang, Fang Wang, Xiaonan Li, et al.
Colloids and Surfaces B Biointerfaces (2019) Vol. 177, pp. 425-432
Closed Access | Times Cited: 38
Design of Experiments in Pharmaceutical Development
Abhishek Sunil Dhoot, Gasper Fernandes, Anup Naha, et al.
Pharmaceutical Chemistry Journal (2019) Vol. 53, Iss. 8, pp. 730-735
Closed Access | Times Cited: 37
Evaluation of potential environmental toxicity of polymeric nanomaterials and surfactants
Indra Hering, Elke Eilebrecht, Michael J. Parnham, et al.
Environmental Toxicology and Pharmacology (2020) Vol. 76, pp. 103353-103353
Closed Access | Times Cited: 33
PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Fars K. Alanazi, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3287-3311
Open Access | Times Cited: 22
Development and Evaluation of Stable Long Circulating Decitabine-loaded Copolymeric Nanoparticles: Harnessing QbD Approach and Lyophilization Technique
Parameswar Patra, Sumeet Katke, Sonali Singh, et al.
Journal of Pharmaceutical Innovation (2024) Vol. 19, Iss. 3
Closed Access | Times Cited: 4
Unveiling the Potential of Nanosuspension Formulation Strategy for Improved Oral Bioavailability of Gefitinib
Parvez Sayyad, Shikha Jha, Reena Sharma, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 2
Closed Access
Quality by design (QbD) based systematic development of nanobiosystems
Smita Bonde, Chandrakant Bonde, Mayank Sharma, et al.
Elsevier eBooks (2025), pp. 183-211
Closed Access
Formulation and evaluation of HPMC and pullulan-based rapidly dissolving films containing cilnidipine nanosuspension
Shirleen Miriam Marques, Salwa, Cherry Lewis, et al.
International Journal of Biological Macromolecules (2025), pp. 143329-143329
Closed Access
Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation
Maie S. Taha, Smrithi Padmakumar, Amit Singh, et al.
Drug Delivery and Translational Research (2020) Vol. 10, Iss. 3, pp. 766-790
Closed Access | Times Cited: 32
Development of novel S PC-3 gefitinib lipid nanoparticles for effective drug delivery in breast cancer. Tissue distribution studies and cell cytotoxicity analysis
SUJIT NAYEK, Nulgumnalli Manjunathaiah Raghavendra, B. Sajeev Kumar
Journal of Drug Delivery Science and Technology (2020) Vol. 61, pp. 102073-102073
Closed Access | Times Cited: 32
Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer
Yuping Zhao, Muhammad Bilal, Ali Raza, et al.
International Journal of Biological Macromolecules (2020) Vol. 168, pp. 22-37
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top